News
A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea - Gut
Background Irritable bowel syndrome with diarrhoea (IBS-D) is particularly debilitating due to urgency and episodic incontinence. Some 5-hydroxytryptamine 3 (5-HT3) receptor antagonists (5-HT3RAs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback